194 related articles for article (PubMed ID: 23198655)
1. [Rheumatoid arthritis: strategies for biotherapy].
Nau JY
Rev Med Suisse; 2012 Oct; 8(358):1988-9. PubMed ID: 23198655
[No Abstract] [Full Text] [Related]
2. Biological therapy for rheumatoid arthritis: where are we now?
Horton SC; Emery P
Br J Hosp Med (Lond); 2012 Jan; 73(1):12-8. PubMed ID: 22241404
[TBL] [Abstract][Full Text] [Related]
3. Strategies after the failure of the first anti-tumor necrosis factor alpha agent in rheumatoid arthritis.
Papagoras C; Voulgari PV; Drosos AA
Autoimmun Rev; 2010 Jun; 9(8):574-82. PubMed ID: 20433955
[TBL] [Abstract][Full Text] [Related]
4. Use of abatacept in rheumatoid arthritis.
von Kempis J; Dudler J; Hasler P; Kyburz D; Tyndall A; Zufferey P; Villiger PM
Swiss Med Wkly; 2012; 142():w13581. PubMed ID: 22581564
[TBL] [Abstract][Full Text] [Related]
5. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
[No Abstract] [Full Text] [Related]
6. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.
Grasland A; Sterpu R; Boussoukaya S; Mahe I
Eur J Clin Pharmacol; 2012 May; 68(5):895-8. PubMed ID: 22205272
[No Abstract] [Full Text] [Related]
8. Adalimumab for rheumatoid arthritis?
Ebell M; Kripke C
Am Fam Physician; 2006 Feb; 73(3):435-6. PubMed ID: 16479667
[No Abstract] [Full Text] [Related]
9. Rheumatoid arthritis.
Burchini G; Orsi C
N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
[No Abstract] [Full Text] [Related]
10. A decade of data discloses the window is still not clear.
Cohen M
J Rheumatol; 2014 Jan; 41(1):1-2. PubMed ID: 24382923
[No Abstract] [Full Text] [Related]
11. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes.
Bathon J; Robles M; Ximenes AC; Nayiager S; Wollenhaupt J; Durez P; Gomez-Reino J; Grassi W; Haraoui B; Shergy W; Park SH; Genant H; Peterfy C; Becker JC; Covucci A; Moniz Reed D; Helfrick R; Westhovens R
Ann Rheum Dis; 2011 Nov; 70(11):1949-56. PubMed ID: 21821865
[TBL] [Abstract][Full Text] [Related]
12. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
13. When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
Smolen JS; Weinblatt ME
Ann Rheum Dis; 2008 Nov; 67(11):1497-8. PubMed ID: 18854512
[No Abstract] [Full Text] [Related]
14. [Non-TNF biologicals in the therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J; Krüger K
Z Rheumatol; 2010 Sep; 69(7):618-25. PubMed ID: 20703488
[TBL] [Abstract][Full Text] [Related]
15. Biological disease modifying anti-rheumatic drugs.
Cranwell-Bruce LA
Medsurg Nurs; 2011; 20(3):147-50. PubMed ID: 21786492
[No Abstract] [Full Text] [Related]
16. Abatacept: a novel treatment for rheumatoid arthritis.
Lundquist LM
Expert Opin Pharmacother; 2007 Oct; 8(14):2371-9. PubMed ID: 17927490
[TBL] [Abstract][Full Text] [Related]
17. [Recent topics on new biological agents for treatment of rheumatoid arthritis].
Saito K; Tanaka Y
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2418-23. PubMed ID: 19149039
[No Abstract] [Full Text] [Related]
18. Perspectives on rheumatoid arthritis for the orthopedic surgeon: overview of non-tumor necrosis factor biologic drugs and perioperative management.
Keith MP
Am J Orthop (Belle Mead NJ); 2011 Dec; 40(12):E272-5. PubMed ID: 22268021
[TBL] [Abstract][Full Text] [Related]
19. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].
Swierkot J; Madej M
Pol Merkur Lekarski; 2011 Apr; 30(178):289-94. PubMed ID: 21595177
[TBL] [Abstract][Full Text] [Related]
20. New therapies for treatment of rheumatoid arthritis.
Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P
Lancet; 2007 Dec; 370(9602):1861-74. PubMed ID: 17570481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]